{
  "actions": [
    {
      "acted_at": "2023-09-21",
      "action_code": "10000",
      "references": [],
      "text": "Introduced in Senate",
      "type": "action"
    },
    {
      "acted_at": "2023-09-21",
      "action_code": "",
      "committees": [
        "SSHR"
      ],
      "references": [],
      "status": "REFERRED",
      "text": "Read twice and referred to the Committee on Health, Education, Labor, and Pensions.",
      "type": "referral"
    }
  ],
  "amendments": [],
  "bill_id": "s2886-118",
  "bill_type": "s",
  "by_request": false,
  "committee_reports": [],
  "committees": [
    {
      "activity": [
        "Referred To"
      ],
      "committee": "Senate Health, Education, Labor, and Pensions",
      "committee_id": "SSHR"
    }
  ],
  "congress": "118",
  "cosponsors": [
    {
      "bioguide_id": "B001277",
      "district": null,
      "name": "Blumenthal, Richard",
      "original_cosponsor": true,
      "sponsored_at": "2023-09-21",
      "state": "CT",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "B000944",
      "district": null,
      "name": "Brown, Sherrod",
      "original_cosponsor": true,
      "sponsored_at": "2023-09-21",
      "state": "OH",
      "title": "Sen.",
      "withdrawn_at": null
    },
    {
      "bioguide_id": "C001088",
      "district": null,
      "name": "Coons, Christopher A.",
      "original_cosponsor": true,
      "sponsored_at": "2023-09-21",
      "state": "DE",
      "title": "Sen.",
      "withdrawn_at": null
    }
  ],
  "enacted_as": null,
  "history": {
    "active": false,
    "awaiting_signature": false,
    "enacted": false,
    "vetoed": false
  },
  "introduced_at": "2023-09-21",
  "number": "2886",
  "official_title": "A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.",
  "popular_title": null,
  "related_bills": [],
  "short_title": "Updated Drug Labeling for Patient Safety Act",
  "sponsor": {
    "bioguide_id": "V000128",
    "district": null,
    "name": "Van Hollen, Chris",
    "state": "MD",
    "title": "Sen.",
    "type": "person"
  },
  "status": "REFERRED",
  "status_at": "2023-09-21",
  "subjects": [
    "Health"
  ],
  "subjects_top_term": "Health",
  "summary": null,
  "titles": [
    {
      "as": null,
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Updated Drug Labeling for Patient Safety Act",
      "type": "display"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "Updated Drug Labeling for Patient Safety Act",
      "type": "short"
    },
    {
      "as": "introduced",
      "is_for_portion": false,
      "textVersionCode": null,
      "title": "A bill to permit manufacturers of generic drugs to provide additional warnings with respect to such drugs in the same manner that the Food and Drug Administration allows brand names to do so.",
      "type": "official"
    }
  ],
  "updated_at": "2025-05-27T14:16:45Z",
  "url": "https://www.govinfo.gov/bulkdata/BILLSTATUS/118/s/BILLSTATUS-118s2886.xml"
}